Assignee
DANATLAS PHARMACEUTICALS CO LTD
CN·0 granted patents·5 pending applications·0 citations·filing 2023–2025
Top patents by PatentIndex Score
5 records- 0173US2025388589A1Tricyclic heterocyclic derivatives, compositions and uses thereofDANATLAS PHARMACEUTICALS CO LTD·Filed 2025·Application pending·0 cites
- 0269US2024140954A1Tricyclic heterocyclic derivatives, compositions and uses thereofDANATLAS PHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 0365US2026034113A1Thiadiazolone derivatives, compositions and uses thereofDANATLAS PHARMACEUTICALS CO LTD·Filed 2025·Application pending·0 cites
- 0463US2026049088A1Tricyclic heterocyclic derivatives, compositions and uses thereofDANATLAS PHARMACEUTICALS CO LTD·Filed 2025·Application pending·0 cites
- 0563US2026015358A1Bicyclic derivatives, compositions and uses thereofDANATLAS PHARMACEUTICALS CO LTD·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when DANATLAS PHARMACEUTICALS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →